Immunome Inc.

IMNM chart

Immunome Inc. news

• Immunome, Inc. Stock 12‑Month Price Target Cut to $35.13, Implies 81% Upside

  TradingView · Nov 10, 2:20 PM EST

• Immunome Inc (IMNM) Selling Stockholders Plan to Offer 4.43 Mill

  GuruFocus · Nov 10, 1:10 PM EST

• Does Regulatory Progress Change The Bull Case For Immunome Stock (IMNM)?

  Simply Wall St · Nov 10, 11:18 AM EST

• Piper Sandler lowers Immunome stock price target to $30 on higher costs

  Investing.com · Nov 10, 10:26 AM EST

• Immunome Analysts Cut Their Forecasts After Q3 Results

  Benzinga · Nov 10, 10:22 AM EST

• Immunome at guggenheim healthcare innovation conference: launch near By Investing.com

  Investing.com UK · Nov 10, 9:38 AM EST

• Immunome, Inc. Stock 12‑Month Price Target Cut to $35.07, Implies 81% Upside

  TradingView · Nov 10, 5:20 AM EST

• Immunome, Inc. (IMNM) Misses Q3 EPS by 16c

  StreetInsider · Nov 9, 5:26 PM EST

• Immunome (IMNM) Advances Oncology Pipeline with Varegacestat FDA and EMA Milestones

  GuruFocus · Nov 9, 5:25 PM EST

• After $65.9M in prior share sales, Immunome (IMNM) may sell more stock.

  Stock Titan · Nov 9, 5:00 PM EST

• Immunome 3Q 2026: Revenue $0, EPS ($0.76) — 10-Q Summary

  TradingView · Nov 9, 4:21 PM EST

• Immunome Reports $85.8 Million Q3 Net Loss and Advances Oncology Pipeline

  TradingView · Nov 9, 4:13 PM EST

Immunome Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-09
• 8-K8-K2026-11-09
• 8-K8-K2026-10-05
• 10-Q10-Q2026-08-11
• 8-K8-K2026-08-11
• 8-K8-K2026-06-12
• 10-Q10-Q2026-05-12
• 8-K8-K2026-05-12
• DEF 14ADEF 14A2026-04-24
• 10-K10-K2026-03-03
• 8-K8-K2026-03-03
• 8-K8-K2025-12-17

About Immunome Inc.

Ticker

IMNM (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Bothell, WA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1472012

Frequently asked questions